JPWO2021222831A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021222831A5 JPWO2021222831A5 JP2022566315A JP2022566315A JPWO2021222831A5 JP WO2021222831 A5 JPWO2021222831 A5 JP WO2021222831A5 JP 2022566315 A JP2022566315 A JP 2022566315A JP 2022566315 A JP2022566315 A JP 2022566315A JP WO2021222831 A5 JPWO2021222831 A5 JP WO2021222831A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- mutation
- polypeptide
- viral
- vector system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063019221P | 2020-05-01 | 2020-05-01 | |
| US63/019,221 | 2020-05-01 | ||
| US202063061517P | 2020-08-05 | 2020-08-05 | |
| US63/061,517 | 2020-08-05 | ||
| PCT/US2021/030298 WO2021222831A2 (en) | 2020-05-01 | 2021-04-30 | Engineered central nervous system compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524061A JP2023524061A (ja) | 2023-06-08 |
| JP2023524061A5 JP2023524061A5 (https=) | 2024-05-13 |
| JPWO2021222831A5 true JPWO2021222831A5 (https=) | 2024-05-13 |
Family
ID=78373993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566315A Withdrawn JP2023524061A (ja) | 2020-05-01 | 2021-04-30 | 操作された中枢神経系用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230193316A1 (https=) |
| EP (1) | EP4143305A4 (https=) |
| JP (1) | JP2023524061A (https=) |
| CN (1) | CN115867646A (https=) |
| AU (1) | AU2021264061A1 (https=) |
| CA (1) | CA3176506A1 (https=) |
| WO (1) | WO2021222831A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3861010A1 (en) | 2018-10-02 | 2021-08-11 | Voyager Therapeutics, Inc. | Redirection of tropism of aav capsids |
| CN116096734A (zh) | 2020-05-13 | 2023-05-09 | 沃雅戈治疗公司 | Aav衣壳的向性的重定向 |
| WO2022173847A2 (en) * | 2021-02-09 | 2022-08-18 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| CA3216419A1 (en) * | 2021-04-23 | 2022-10-27 | Greg NACHTRAB | Tissue-targeted modified aav capsids and methods of use thereof |
| WO2022226375A1 (en) * | 2021-04-23 | 2022-10-27 | Locanabio, Inc. | Tissue-targeted modified aav capsids and methods of use thereof |
| MX2024004217A (es) | 2021-10-08 | 2024-06-26 | Dyno Therapeutics Inc | Variantes de cápside y métodos de uso de estas. |
| MX2024004936A (es) | 2021-11-02 | 2024-05-08 | Voyager Therapeutics Inc | Variantes de capsides de aav y sus usos. |
| US20260085284A1 (en) * | 2022-08-30 | 2026-03-26 | Shanghai Genemagic Biosciences Co., Ltd. | Method for trans-differentiating non-neuronal cells into neurons and use thereof |
| WO2024086747A1 (en) | 2022-10-19 | 2024-04-25 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| TW202502803A (zh) | 2023-03-10 | 2025-01-16 | 美商戴諾治療公司 | 衣殼多肽及其使用方法 |
| WO2024238807A2 (en) | 2023-05-16 | 2024-11-21 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| AR133098A1 (es) * | 2023-06-29 | 2025-08-27 | Univ Pennsylvania | Aav mutante con motivos dirigidos al sistema nervioso central y composiciones que lo contienen |
| TW202525832A (zh) | 2023-08-31 | 2025-07-01 | 美商戴諾治療公司 | 衣殼多肽及其使用方法(二) |
| CN117165677A (zh) * | 2023-11-03 | 2023-12-05 | 首都儿科研究所 | 检测生物标志物在制备神经管畸形疾病的产品的应用 |
| WO2025160155A1 (en) | 2024-01-22 | 2025-07-31 | The Broad Institute, Inc. | Epigenetic targeting of prion diseases |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014139182A1 (en) * | 2013-03-15 | 2014-09-18 | Shenzhen Hightide Biopharmaceutical, Ltd. | Compositions and methods of using islet neogenesis peptides and analogs thereof |
| WO2016081811A1 (en) * | 2014-11-21 | 2016-05-26 | The University Of North Carolina At Chapel Hill | Aav vectors targeted to the central nervous system |
| CA2988388C (en) * | 2015-04-23 | 2022-11-22 | Nantomics, Llc | Cancer neoepitopes |
| KR102423442B1 (ko) * | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| NZ763617A (en) * | 2017-10-16 | 2026-01-30 | Vigeneron Gmbh | Aav vectors |
| IL278598B2 (en) * | 2018-05-11 | 2025-11-01 | Massachusetts Eye & Ear Infirmary | Altering tissue tropism of adeno-associated viruses |
| US20210277418A1 (en) * | 2018-08-03 | 2021-09-09 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
| EP3861010A1 (en) * | 2018-10-02 | 2021-08-11 | Voyager Therapeutics, Inc. | Redirection of tropism of aav capsids |
| WO2023039480A2 (en) * | 2021-09-08 | 2023-03-16 | The Broad Institute, Inc. | Engineered central nervous system compositions |
-
2021
- 2021-04-30 AU AU2021264061A patent/AU2021264061A1/en active Pending
- 2021-04-30 CA CA3176506A patent/CA3176506A1/en active Pending
- 2021-04-30 WO PCT/US2021/030298 patent/WO2021222831A2/en not_active Ceased
- 2021-04-30 JP JP2022566315A patent/JP2023524061A/ja not_active Withdrawn
- 2021-04-30 EP EP21795362.9A patent/EP4143305A4/en active Pending
- 2021-04-30 US US17/922,437 patent/US20230193316A1/en active Pending
- 2021-04-30 CN CN202180042776.8A patent/CN115867646A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021222831A5 (https=) | ||
| JPWO2022020616A5 (https=) | ||
| EP1135468B1 (en) | Virus vectors and methods of making and administering the same | |
| JP2021516046A5 (https=) | ||
| JP2024009857A5 (https=) | ||
| EP1456383B1 (en) | A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism | |
| JP6174318B2 (ja) | アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物 | |
| JPWO2021077000A5 (https=) | ||
| JP2021512649A5 (https=) | ||
| JP2022068181A5 (https=) | ||
| JP2007507223A5 (https=) | ||
| JP2020522269A5 (https=) | ||
| JP2024099770A5 (https=) | ||
| JPWO2019168961A5 (https=) | ||
| JP2021523702A5 (https=) | ||
| AU2019383490A1 (en) | Liver-specific viral promoters and methods of using the same | |
| JPWO2020214609A5 (https=) | ||
| JP2021531044A5 (https=) | ||
| JPWO2022226374A5 (https=) | ||
| JPWO2020214613A5 (https=) | ||
| CN120787264A (zh) | 肝脏去靶向衣壳 | |
| JPWO2022036220A5 (https=) | ||
| JPWO2019213668A5 (https=) | ||
| JPWO2023060142A5 (https=) | ||
| JP2025515356A5 (https=) |